Home » Topics » Cardiovascular, BioWorld Science

Cardiovascular, BioWorld Science
RSS

European patent protection issued for Hyal's hyaluronan technology

Aug. 23, 1996

Apolipoprotein A-IV as atherosclerosis treatment

Aug. 23, 1996

More endothelin converting enzyme inhibitors from Warner-Lambert

Aug. 23, 1996

Ciba-Geigy claims endothelin converting enzyme inhibitors

Aug. 23, 1996

Roche discloses ETA antagonists for circulatory disorders

Aug. 23, 1996

Endothelin ETA inhibitors described by Roche

Aug. 23, 1996

New calcium entry blocker described by Italian researchers

Aug. 23, 1996

Favorable safety review for Neuprex

Aug. 16, 1996

Pilot study results reported for CytoTAb

Aug. 16, 1996

PLC Systems granted patent integral to Heart Laser technology

Aug. 16, 1996

Popular Stories

Today's news in brief
BioWorld
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...